Height Test

Your height is one of the most underappreciated health markers you already have. By the time you stop growing, your adult stature has quietly encoded decades of biological history: how well you were nourished, how much growth hormone your body produced, whether chronic illness or hormonal imbalance interfered with your development. That number on the wall chart is not just a physical trait. It is a record of your body's earliest environment, and it carries real consequences for your risk of heart disease, cancer, blood clots, and even how long you are likely to live.

Large studies involving millions of people have shown that height is independently associated with at least a dozen major diseases. Shorter adults face higher cardiovascular risk. Taller adults face higher cancer risk. These associations persist even after adjusting for weight, income, smoking, and other obvious confounders. Understanding where your height places you on these risk curves can help you prioritize screening and prevention strategies that standard bloodwork does not address.

How Height Is Determined

About 80% of the variation in adult height comes from genetics, with over 700 identified gene variants playing a role. The remaining 20% is shaped by nutrition, hormones, illness burden, and socioeconomic conditions during childhood and adolescence. The primary hormonal driver is the growth hormone and IGF-1 (insulin-like growth factor 1) axis: your pituitary gland releases growth hormone, which stimulates your liver and other tissues to produce IGF-1, and together these signals drive the elongation of your bones at specialized zones of cartilage called growth plates.

Growth plates close after puberty, which is why adult height is essentially fixed. Thyroid hormones, sex hormones, and adequate nutrition all play supporting roles. When any of these systems fail during childhood, whether from hormonal deficiency, chronic disease, or malnutrition, the result is shorter adult stature. This is why height functions as a biological archive of your early-life health.

Heart Disease Risk

Shorter stature is consistently linked to higher cardiovascular risk. A meta-analysis of 17 studies covering over 2.6 million people and more than 95,000 cardiovascular deaths found that those in the tallest height groups had about 20% lower risk of dying from cardiovascular disease compared to the shortest groups. The association held for both coronary heart disease (about 18% lower risk for taller individuals) and stroke (about 27% lower risk).

A Korean nationwide study of over 16.5 million adults confirmed this pattern across heart attacks, heart failure, stroke, and death, with the association persisting after adjusting for blood pressure, cholesterol, diabetes, income, and lifestyle factors. However, geography matters. The international PURE study, which followed more than 154,000 people across 21 countries, found that the height-cardiovascular link was strongest in low-income countries and essentially disappeared in high-income countries. This suggests that the connection is partly driven by childhood poverty and malnutrition rather than height itself.

Cancer Risk

While shorter people have more heart disease, taller people face higher cancer rates, and the association is strikingly consistent. The Million Women Study tracked over 1.29 million women for nearly a decade and found that each 10 cm (about 4 inches) of additional height increased overall cancer risk by 16%. The strongest associations were with melanoma (32% higher risk per 10 cm), kidney cancer (29% higher), colon cancer (25% higher), and leukemia (26% higher).

A Swedish study of 5.5 million adults largely confirmed these findings, with melanoma again showing the strongest link. A Korean cohort of nearly 23 million people found a 9% increase in overall cancer risk per 5 cm of additional height, with thyroid, breast, lymphoma, testicular, and kidney cancers showing the highest associations. The proposed mechanism involves taller people having more cells and higher levels of growth-promoting hormones like IGF-1, both of which may increase the statistical opportunity for a cell to become cancerous.

Blood Clot Risk

Taller adults are more likely to develop venous thromboembolism (blood clots in the deep veins or lungs). A combined Scandinavian cohort of more than 114,000 people found that each 10 cm of additional height raised blood clot risk by 34% in men and 23% in women. The Dutch MEGA study found even more striking numbers: men between 195 and 200 cm tall had about 2.9 times the risk of a first blood clot compared to men 165 to 170 cm tall, and men over 200 cm had roughly 3.8 times the risk.

A Mendelian randomization study, which uses genetic variants to test whether the association is likely causal, supported a real biological connection between height and clot risk. The leading theory is that taller people have longer veins in their legs, which creates more opportunity for blood to slow and pool, especially during prolonged sitting or immobility.

Type 2 Diabetes

Shorter adults have a modestly higher risk of developing type 2 diabetes. A meta-analysis of 16 studies covering more than 261,000 people found about a 12% reduction in diabetes risk per standard increment of height. A German cohort of over 783,000 outpatients confirmed this, with each 10 cm decrease in height associated with a 15% higher risk in women and 10% higher risk in men. The connection may involve shorter people having proportionally higher liver fat and less favorable metabolic profiles for their body size.

All-Cause Mortality

The relationship between height and overall lifespan is not a straight line. A meta-analysis of over 2.8 million people found the lowest mortality risk at about 174 cm (5 feet 8.5 inches) for men and 158 cm (5 feet 2 inches) for women, with risk rising at both extremes. This makes sense given the opposing forces: shorter stature increases cardiovascular risk, while taller stature increases cancer risk. The sweet spot falls somewhere in between.

A large individual-participant meta-analysis of over 1 million people from 121 studies found that each 6.5 cm of additional height was associated with a 6% lower risk of dying from vascular causes but a 4% higher risk of dying from cancer, roughly canceling each other out for overall mortality. Interestingly, a study of Japanese-American men found that shorter men lived longer, with shorter stature linked to a longevity-promoting gene variant called FOXO3 and lower fasting insulin levels.

Reference Ranges

Height is not interpreted using the fixed reference ranges that apply to blood tests. Instead, it is assessed relative to population norms based on age, sex, and ethnicity. For children, the World Health Organization provides growth standards for birth through age 5, and the CDC provides growth reference charts for ages 2 through 20. A child's height is expressed as a percentile or a standard deviation (SD) score, which shows where they fall relative to other children of the same age and sex.

For adults, the most useful clinical thresholds involve height loss over time rather than absolute height. Current guidelines recommend spinal imaging when height loss exceeds 2 cm within 3 years or 4 cm from your peak adult height, as this pattern predicts vertebral compression fractures and osteoporosis.

Population averages vary significantly by country. The tallest average heights are found in the Netherlands (about 184 cm for men, 170 cm for women), while the shortest are in parts of Southeast Asia and Central America (about 160 cm for men, 151 cm for women). Within any population, your own percentile matters more than your absolute number.

Tracking Your Trend

For children and adolescents, serial height measurements plotted on a growth chart over time are far more informative than any single reading. A child who consistently tracks along the 25th percentile is growing normally. A child who drops from the 50th to the 10th percentile over a year has a growth velocity problem that deserves investigation, even though their absolute height might still be within the normal range. Growth velocity should be assessed over at least 3 to 6 month intervals.

For adults, height should be measured at every physical exam and compared to your peak adult height. Once you are past age 40, annual measurements become particularly valuable for catching the early signs of vertebral fractures and spinal degeneration. Average height loss is about 1 mm per year starting in your 30s, accelerating after age 50. Losing more than 0.5 cm per year roughly doubles your risk of hip fracture and significantly raises your risk of any fracture. If you notice you are getting shorter, do not dismiss it as normal aging. Get your spine evaluated.

When Results Can Be Misleading

Height varies throughout the day by about 1 to 1.4 cm in adults, with you being tallest in the morning and shortest by evening. About half to three-quarters of this daily shrinkage happens in the first 1 to 3 hours after getting out of bed, as gravity compresses the discs between your vertebrae. For consistent tracking, always measure at the same time of day, ideally in the late afternoon or evening when variation is minimal.

Measurement technique is a surprisingly large source of error. A study found that 9% of clinical stadiometers (the devices used to measure height) had errors exceeding 1.5 cm, and 50% of clinic staff admitted to sometimes entering patient-reported height rather than actually measuring it. Electronic health records showed that 18% of patients had recorded height differences of 2 cm or more over just three months, a period too short for any real change. If your height seems to have changed significantly, confirm it with a second measurement using proper technique: shoes off, heels and back against the wall, eyes looking straight ahead.

Self-reported height is unreliable. Adults consistently overestimate their height, with older adults and men overreporting the most. This leads to BMI underestimation and can cause misclassification of obesity in 3 to 8% of people. Always use a measured height for clinical decisions.